Anthera Pharmaceuticals, Inc. (ANTH) Reports 2013 First Quarter Financial Results
5/14/2013 6:57:16 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HAYWARD, Calif., May 13, 2013 — /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st, 2013.
First Quarter 2013 Financial Results:
Loss from operations, which included a non-recurring and non-cash charge of approximately $1.5 million in stock-based compensation, was $6.9 million for the first quarter of 2013, compared to $20.1 million for the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.